医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

心臓学

Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR in Australia

Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR in Australia

バイオテクノロジーヘルスケアヘルス一般医療機器外科心臓学感染症　 TimeLine: Gore Announces First Commercial In-Human Use Thoracic Stent Graft with ACTIVE CONTROL System

2018年07月03日

0

アラブ首長国連邦保健・予防省、Eve™搭載Masimo Rad-97™ Pulse CO-Oximeters®を使用した全国的な新生児CCHDスクリーニングプログラムを採用

アラブ首長国連邦保健・予防省、Eve™搭載Masimo Rad-97™ Pulse CO-Oximeters®を使用した全国的な新生児CCHDスクリーニングプログラムを採用

ヘルスケア医療機器医療用品心臓学病院　 TimeLine: Eve™搭載Masimo Rad-97 Pulse CO-Oximeters 新生児CCHDスクリーニングプログラム

2018年06月29日

0

Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for Commercializing LIXIANA® in the Philippines, Malaysia and Singapore

Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for Commercializing LIXIANA® in the Philippines, Malaysia and Singapore

バイオテクノロジーヘルスケア心臓学製薬　 TimeLine: Daiichi Sankyo and Menarini Enter into Exclusive for Commercializing LIXIANA Malaysia and Singapore

2018年06月29日

0

阿联酋卫生部采用搭配Eve™的Masimo Rad-97™脉搏碳氧氧饱和度仪®实施全国性CCHD新生儿筛查项目

阿联酋卫生部采用搭配Eve™的Masimo Rad-97™脉搏碳氧氧饱和度仪®实施全国性CCHD新生儿筛查项目

ヘルスケア医療機器医療用品心臓学病院　 TimeLine: 阿联酋卫生部采用

2018年06月29日

0

Corindus Announces Pharmaceutical and Medical Device Agency (PMDA) Approval of CorPath GRX System in Japan

Corindus Announces Pharmaceutical and Medical Device Agency (PMDA) Approval of CorPath GRX System in Japan

ヘルスケア医療機器外科心臓学　 TimeLine: Approval of CorPath GRX System in Japan Corindus Announces Pharmaceutical and Medical

2018年06月08日

0

AtriCure and Baheal Group Establish Partnership and China Distribution Agreement

AtriCure and Baheal Group Establish Partnership and China Distribution Agreement

その他ヘルスバイオテクノロジーヘルスケア医療機器外科心臓学病院臨床試験製薬　 TimeLine: AtriCure and Baheal Group Establish Partnership Distribution Agreement

2018年06月05日

0

Samsung Bioepis Announces Results of Additional One-Year Follow-up Study on SB3 Trastuzumab Biosimilar Candidate at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Samsung Bioepis Announces Results of Additional One-Year Follow-up Study on SB3 Trastuzumab Biosimilar Candidate at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

バイオテクノロジーヘルスケア外科心臓学腫瘍学製薬　 TimeLine: Samsung Bioepis Announces Results of Additional Society of Clinical Oncology Study on SB3 Trastuzumab Biosimilar Candidate

2018年06月01日

0

Analytics 4 Life®的医学顾问委员会新增全球心内科专家

Analytics 4 Life®的医学顾问委员会新增全球心内科专家

ヘルスケア医療機器心臓学臨床試験　 TimeLine: Analytics 4 Life®的医学

2018年05月25日

0

Research Paper Co-authored by Dr. Damien Bates, Chief Medical Officer and Head of Medical Research at SanBio Group, Published in Stroke

Research Paper Co-authored by Dr. Damien Bates, Chief Medical Officer and Head of Medical Research at SanBio Group, Published in Stroke

バイオテクノロジーヘルスケア幹細胞心臓学臨床試験製薬　 TimeLine: and Head of Medical Research at SanBio Chief Medical Officer Damien Bates Published in Stroke Research Paper Co-authored by Dr

2018年05月25日

0

Analytics 4 Life® Expands Its Medical Advisory Board with Global Experts in Cardiology

Analytics 4 Life® Expands Its Medical Advisory Board with Global Experts in Cardiology

ヘルスケア医療機器心臓学臨床試験　 TimeLine: Analytics 4 Life Expands Its Medical Advisory Board with Global Experts in Cardiology

2018年05月23日

0